CARA DEPANFILIS: Open Payments
NPI 1922003508 · NORFOLK, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,677 in 41 payments from 25 companies in 2025. Trend: 2023 $2,869 · 2024 $3,666 · 2025 $3,677
Food & beverage: $3,446Education: $231
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 6 | $532 |
| Janssen Biotech, Inc. | 3 | $392 |
| Incyte Corporation | 2 | $240 |
| GENZYME CORPORATION | 3 | $239 |
| ABBVIE INC. | 4 | $172 |
| Amgen Inc. | 1 | $163 |
| E.R. Squibb & Sons, L.L.C. | 2 | $146 |
| Ipsen Biopharmaceuticals, Inc | 1 | $141 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $135 |
| Genentech, Inc. | 1 | $132 |
Products named: RYBREVANT, EVENITY, Onivyde, Zynyz, Itovebi, KEYTRUDA, PADCEV, Vanflyta.
Industry payments across VA — which companies pay providers there.
